Sign Out
Zifam Linglip is indicated in the treatment of type 2 diabetes mellitus to improve glycaemic control in adults: As monotherapy: In patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to intolerance, or contraindicated due to renal impairment.
As combination therapy: In combination with metformin when diet and exercise plus metformin alone do not provide adequate glycaemic control.
In combination with a sulphonylurea and metformin when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control.
In combination with insulin with or without metformin, when this regimen alone, with diet and exercise, does not provide adequate glycaemic control.
